Cancer-associated thrombosis (CAT) is a condition in which relevance has been
increasingly recognised both for physicians that deal with venous thromboembolism (VTE) …

Tumoral pulmonary hypertension (PH) comprises a variety of subtypes in patients with a
current or previous malignancy. Tumoral PH principally includes the tumour-related …

Cancer patients face an increased risk of arterial thromboembolism; however, it is uncertain
when this excess risk begins. This study evaluated the risk of arterial thromboembolism …

Background: Patients treated with antithrombotic drugs are at risk of bleeding. Bleeding may
be the first manifestation of underlying cancer. Methods: We examined new cancers …

Cancer is a serious health issue, which is one of the leading causes of death in this century.
Cancer at the early stage is more likely to be curable, therefore early detection is an effective …

Background Compact fibrin clots relatively resistant to lysis are observed in patients at
increased risk of venous thromboembolism (VTE) including malignancy. The citrullinated …

It is unknown whether the risk factor profile for mesenteric venous thrombosis (MVT) is
different from systemic venous thromboembolism (VTE). The aim of the present population …

Background Etiological factors, such as a malignant disease, in young stroke patients are
often neglected. Therefore, in this study, we aimed to investigate the risk of developing …

Abstract Purpose of Review Venous thromboembolism (VTE) is a common condition with
significant associated morbidity and mortality. Recurrent VTE after an initial episode is a …

Background Unprovoked venous thromboembolism (VTE) may be the first manifestation of
an underlying cancer. We aimed to assess the period prevalence of occult cancer detection …